Premier Alternatives

CiRC Biosciences

Chicago, IL · Founded 2019 · Privately Held (backing)

Developer of cell-based therapies designed to offer treatments for serious diseases with high unmet needs, with an initial focus on blindness. CiRC Biosciences is based in Chicago, IL and was founded in 2019. Its last reported valuation was $24 million in Dec 2020. It has raised $39.1 million across 2 recorded rounds; the latest was a $7 million debt round in Apr 2024.

Last reported valuation
$24.0M
Oct 2026
Priced at
—
Total raised
$39.1M
Last round
Debt
Apr 2024

CiRC Biosciences key facts

as of Oct 2026
  • Developer of cell-based therapies designed to offer treatments for serious diseases with high unmet needs, with an initial focus on blindness.
  • CiRC Biosciences is valued at approximately $24.0M as of Oct 2026 (last reported valuation).
  • It has raised $39.1M across 2 recorded rounds; the latest was Debt ($7.0M) in Apr 2024.
  • Notable investors include Valor Equity Partners, HSC Next, Harmony Biosciences Holdings, Paragon Biosciences, Portal Innovations.
  • CiRC Biosciences has filed 2 Form Ds with the SEC, most recently Oct 2024 ($250K sold to 1 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$24.0M

CiRC Biosciences's last reported valuation, Dec 2020. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of CiRC Biosciences with a free account
  • ·Watch CiRC Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CiRC Biosciences funding rounds

2 rounds
Apr 2024Debt$7.0MSEC filing▮
Feb 2024Seed Round$250KSEC filing▮
Full funding history →

CiRC Biosciences valuation

CiRC Biosciences's last reported valuation was $24 million in Dec 2020. No priced round, secondary trade or fund mark has surfaced since.

How much has CiRC Biosciences raised?

CiRC Biosciences has raised $39.1 million in total; 2 of its rounds are on record. The largest on record was a $7 million debt round in Apr 2024.

CiRC Biosciences has filed 2 Form Ds with the SEC, most recently in Oct 2024 ($250,000 sold to 1 investor).

CiRC Biosciences investors

5 investors are on record for CiRC Biosciences, including Valor Equity Partners, HSC Next, Harmony Biosciences Holdings and Paragon Biosciences. The debt round in Apr 2024 drew 19 investors.

About CiRC Biosciences

Developer of cell-based therapies designed to offer treatments for serious diseases with high unmet needs, with an initial focus on blindness. The company's therapies bypass the need for stem cells by transforming ordinary skin cells into specialized retinal cells using a cocktail of small molecules, enabling patients suffering from retinal diseases to avail of safer, quicker, and cost-effective treatment.

Sector
Healthcare
HQ
Chicago, IL, United States
Founded
2019
Employees
6
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.